
Type-species-anchored Senegalimassilia reconstruction with eleven compact coccobacilli. This genus plate is representative, non-universal, non-diagnostic, and not a micrograph.
Scientific media record1 verified identifier
- Subject
- Senegalimassiliataxon · genus
- Identifiers
- NCBITaxon:1473205
- Review
- Editorial review completeIdentifiers authority-verified · Accessibility validated · · senegalimassilia|senegalimassilia-morphology-v1.webp
- Digital source
- Trained-algorithmic mediaCreated with a trained generative algorithm and reviewed by WikiBiome for subject identity, scientific framing, identifiers, provenance, and accessibility.
- Scientific basis
- Senegalimassilia — NCBI TaxonomySenegalimassilia — LPSNSenegalimassilia anaerobia primary description
- License
- CC BY-SA 4.0Created
A Gram-positive, obligate anaerobic genus within the phylum Actinobacteria (family Coriobacteriaceae) that has emerged as one of the most frequently identified taxa in Mendelian randomization studies across disparate conditions—erectile dysfunction, chronic kidney disease, hypertension, pancreatic cancer, and epilepsy.
The genus is named after Senegal and Marseille (the isolation sources of early strains) and belongs to the Coriobacteriaceae, a family known for phytoestrogen metabolism and equol production. This metabolic capability may explain why Senegalimassilia appears in hormone-sensitive and vascular conditions with opposing directionality.
Evidence map10 cited passagesInspect provenance +
Senegalimassilia increases ED risk (OR = 1.320-1.355) across two independent MR studies. The mechanism may involve phytoestrogen metabolites modulating nitric oxide-dependent vascular function or androgen metabolism.
Nominally significant CKD risk factor (OR = 1.13, p < 0.05), though not reaching Bonferroni significance (unlike desulfovibrionales).
Senegalimassilia is the most statistically significant protective factor against hypertension (p < 0.01), contrasting sharply with its risk role in ED and CKD. The cardiovascular protection may operate through equol-mediated vasodilation or bile acid signaling.
MR-confirmed protective factor (OR = 0.635), suggesting anti-tumorigenic metabolite production.
Gut Senegalimassilia abundance positively correlates with spasm frequency (r = 0.724, p < 0.001), one of the strongest microbiome-seizure correlations reported.
(MR)—ED risk factor (OR 1.320).
(MR, n=480,698)—Nominally significant CKD risk factor.
(MR)—Most significant protective factor for hypertension.
(MR)—Protective for pancreatic cancer (OR 0.635).
(cross-sectional)—Spasm frequency correlation in epilepsy.
Contents
1. Taxonomy2. Metal Dependencies3. Key Enzymes and Metabolic Features4. Ecological Role5. Conditions Associated6. Key Studies7. Open Questions8. Cross-ReferencesTaxonomy#
Genus Senegalimassilia, family Coriobacteriaceae (or Eggerthellaceae in revised schemes), order Coriobacteriales, class Coriobacteriia, phylum Actinobacteria. S. anaerobia is the type species. Related to other Coriobacteriaceae genera with clinical relevance: Eggerthella, Collinsella, Slackia.
Metal Dependencies#
Iron. Standard iron requirements for anaerobic Actinobacteria metabolism. Coriobacteriaceae generally have modest iron acquisition systems, consistent with their ecological niche as secondary metabolizers rather than primary fermenters.
Key Enzymes and Metabolic Features#
Phytoestrogen metabolism: Coriobacteriaceae, including Senegalimassilia, participate in the conversion of dietary isoflavones (daidzein, genistein) to bioactive metabolites. Some members produce equol, a potent estrogen receptor modulator with cardiovascular and anti-cancer properties.
Bile acid transformation: Coriobacteriaceae contribute to secondary bile acid metabolism, linking them to cholesterol homeostasis and gut-liver axis signaling.
Ecological Role#
In the Healthy Gut#
Senegalimassilia is a low-abundance member of the gut microbiota, typically detected through deep sequencing rather than standard 16S surveys. Its Coriobacteriaceae family membership places it among the secondary metabolizers that process products of primary fermentation (lactate, succinate) and dietary polyphenols.
Multi-Disease MR Profile#
The opposing directionality of Senegalimassilia across conditions is striking and may reflect. Phytoestrogen metabolism: Equol production could be protective in cancer (anti-proliferative) but contributory in erectile dysfunction (estrogen modulation of vascular function). Bile acid effects: Secondary bile acid production may have opposing effects on renal vs. cardiovascular endpoints.
Population-specific effects: MR instruments may capture different Senegalimassilia strains or genetic contexts across GWAS populations.
Conditions Associated#
Erectile Dysfunction (Risk Factor)#
Senegalimassilia increases ED risk (OR = 1.320-1.355) across two independent MR studies.[1]Zhang 2023 — Causal Gut Microbiota and Erectile Dysfunction (Mendelian Randomization)Zhang et al. · 2023Open reference 1 ↓ The mechanism may involve phytoestrogen metabolites modulating nitric oxide-dependent vascular function or androgen metabolism.
Chronic Kidney Disease (Risk Factor)#
Nominally significant CKD risk factor (OR = 1.13, p < 0.05),[2]Luo 2023 — Causal Effects of Gut Microbiota on the Risk of Chronic Kidney Disease: A Mendelian Randomization StudyMingli Luo, Jiahao Cai, Shulu Luo et al. · 2023Open reference 2 ↓ though not reaching Bonferroni significance (unlike Desulfovibrionales).
Hypertension (Protective)#
Senegalimassilia is the most statistically significant protective factor against hypertension (p < 0.01),[3]Causality of gut microbiome and hypertension: A bidirectional mendelian randomization studyYihui Li, Ru Fu, Ruixuan Li et al. · 2023Open reference 3 ↓ contrasting sharply with its risk role in ED and CKD. The cardiovascular protection may operate through equol-mediated vasodilation or bile acid signaling.
Pancreatic Cancer (Protective)#
MR-confirmed protective factor (OR = 0.635),[4]Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization studyZhichen Jiang, Yiping Mou, Huiju Wang et al. · 2023Open reference 4 ↓ suggesting anti-tumorigenic metabolite production.
Cryptogenic Partial Epilepsy#
Gut Senegalimassilia abundance positively correlates with spasm frequency (r = 0.724, p < 0.001),[5]Huang 2022 — Correlations Between Gastrointestinal and Oral Microbiota in Children With Cerebral Palsy and EpilepsyCongfu Huang, Chunuo Chu, Yuanping Peng et al. · 2022Open reference 5 ↓ one of the strongest microbiome-seizure correlations reported.
Key Studies#
[1]Zhang 2023 — Causal Gut Microbiota and Erectile Dysfunction (Mendelian Randomization)Zhang et al. · 2023Open reference 1 ↓ (MR)—ED risk factor (OR 1.320).[2]Luo 2023 — Causal Effects of Gut Microbiota on the Risk of Chronic Kidney Disease: A Mendelian Randomization StudyMingli Luo, Jiahao Cai, Shulu Luo et al. · 2023Open reference 2 ↓ (MR, n=480,698)—Nominally significant CKD risk factor.[3]Causality of gut microbiome and hypertension: A bidirectional mendelian randomization studyYihui Li, Ru Fu, Ruixuan Li et al. · 2023Open reference 3 ↓ (MR)—Most significant protective factor for hypertension.
[4]Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization studyZhichen Jiang, Yiping Mou, Huiju Wang et al. · 2023Open reference 4 ↓ (MR)—Protective for pancreatic cancer (OR 0.635).[5]Huang 2022 — Correlations Between Gastrointestinal and Oral Microbiota in Children With Cerebral Palsy and EpilepsyCongfu Huang, Chunuo Chu, Yuanping Peng et al. · 2022Open reference 5 ↓ (cross-sectional)—Spasm frequency correlation in epilepsy.
Open Questions#
Unresolved questions identified by the current evidence record.
01Why is Senegalimassilia protective for hypertension but a risk factor for ED?+
Both conditions involve vascular function, yet the directionality is opposite. Species-level resolution and metabolomics (equol, bile acids) could resolve this paradox.
02Is equol production the common mechanistic thread?+
If confirmed, dietary isoflavone intake could modulate the effects of Senegalimassilia across conditions.
Cross-References#
- Erectile Dysfunction—causal risk factor via MR
- Chronic Kidney Disease—nominally significant risk factor
- Hypertension—most significant protective taxon
- Pancreatic Cancer—MR-confirmed protective factor
- Eggerthella—related Coriobacteriaceae genus
- Collinsella—related Coriobacteriaceae; CVD associations
- Oscillibacter—co-identified as ED risk factor
References 5
Numbered by first appearance in the article, then reconciled with its declared source list.
- 1
Zhang et al. (2023). Zhang 2023 — Causal Gut Microbiota and Erectile Dysfunction (Mendelian Randomization). Frontiers in Microbiology.
- 2
Mingli Luo, Jiahao Cai, Shulu Luo et al. (2023). Luo 2023 — Causal Effects of Gut Microbiota on the Risk of Chronic Kidney Disease: A Mendelian Randomization Study. Frontiers in Cellular and Infection Microbiology.
- 3
Yihui Li, Ru Fu, Ruixuan Li et al. (2023). Causality of gut microbiome and hypertension: A bidirectional mendelian randomization study. Frontiers in Cardiovascular Medicine.
- 4
Zhichen Jiang, Yiping Mou, Huiju Wang et al. (2023). Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study. BMC Cancer.
- 5
Congfu Huang, Chunuo Chu, Yuanping Peng et al. (2022). Huang 2022 — Correlations Between Gastrointestinal and Oral Microbiota in Children With Cerebral Palsy and Epilepsy. Frontiers in Pediatrics.
Article network
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +10 −10
Inspect exact Git diff ↗ - published revision
pre-overnight checkpoint 2026-04-18
WikiBiome Deploy Bot · +95 −0
Inspect exact Git diff ↗

